About Us

We are a clinical-stage biotechnology company with a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet need, with an internal focus on oncology and immunotherapies.

Orionis Biosciences has research facilities in the Boston area (Waltham, Mass., USA) and Ghent (Belgium), and is operated by a world-class team of scientists, entrepreneurs, and a transatlantic network of investors. The company has collaborations with Novartis, Genentech, the University of Texas MD Anderson Cancer Center, VIB/Ghent University, and Harvard Medical School.

Please contact us if you would like to explore partnership opportunities.